This webinar will present strategies and tools for doing a complete and comprehensive impact assessment of supplier change notices. Tools and procedures for deciding if full impact assessments need to be processed and when notices for lower impact changes can be accepted or rejected without a full assessment will be discussed. Who (what skill sets) should be on the impact assessment team, how often to meet and methods for evaluating change notices will also be discussed. Supplier agreements and quality agreements with suppliers and vendors as well as using risk based approaches to impact assessments will be highlighted.
WHY SHOULD YOU ATTEND?
Any manufacturer of pharmaceutical products or medical devices will have vendors and suppliers in order to acquire the materials needed for manufacturing product. In a regulated environment, the manufacturer is responsible for the quality and source of all incoming materials. When supplier or vendors make changes to material, its own manufacturing or supplier they should tell the manufacturer about these changes via a supplier change notice. Without proper evaluation of the change, unforeseen changes could occur in the product leading to failed manufacturing runs or the release of non-conforming material to market. Regulatory agencies (FDA) expect manufactures to be in control of all incoming material, therefore failure to do a proper impact assessment of supplier changes could also lead to enforcement action and/or product recall. Manufactures need a robust process ensure all vendors and suppliers provide change notices and to evaluate all notices for impact.
AREA COVERED
- Introduction to supplier change notices
- Regulatory impact of supplier change notices
- Risk based approach to categorizing supplier change notices
- Key skill sets needed to evaluate supplier change notices
- Verification and Validation of supplier change notices
- Key tools to help in impact assessments of supplier change notices
LEARNING OBJECTIVES
- Understanding supplier change notices
- Categorization of change notices based on risk
- Setting up a change impact team
- Supplier/vendor quality agreements and supplier agreements
- What happens if the change is unacceptable
- How to set up incoming material specifications
WHO WILL BENEFIT?
- QA professionals
- Technical scientists
- Production staff
- Regulatory Affairs professionals
- Supply chain professionals
Any manufacturer of pharmaceutical products or medical devices will have vendors and suppliers in order to acquire the materials needed for manufacturing product. In a regulated environment, the manufacturer is responsible for the quality and source of all incoming materials. When supplier or vendors make changes to material, its own manufacturing or supplier they should tell the manufacturer about these changes via a supplier change notice. Without proper evaluation of the change, unforeseen changes could occur in the product leading to failed manufacturing runs or the release of non-conforming material to market. Regulatory agencies (FDA) expect manufactures to be in control of all incoming material, therefore failure to do a proper impact assessment of supplier changes could also lead to enforcement action and/or product recall. Manufactures need a robust process ensure all vendors and suppliers provide change notices and to evaluate all notices for impact.
- Introduction to supplier change notices
- Regulatory impact of supplier change notices
- Risk based approach to categorizing supplier change notices
- Key skill sets needed to evaluate supplier change notices
- Verification and Validation of supplier change notices
- Key tools to help in impact assessments of supplier change notices
- Understanding supplier change notices
- Categorization of change notices based on risk
- Setting up a change impact team
- Supplier/vendor quality agreements and supplier agreements
- What happens if the change is unacceptable
- How to set up incoming material specifications
- QA professionals
- Technical scientists
- Production staff
- Regulatory Affairs professionals
- Supply chain professionals
Speaker Profile
Alan M Golden
Alan M Golden has over 30 years of experience in the medical device industry, both in basic research and quality assurance. Alan spent 31 years at Abbott Laboratories. For the first 16 years as part of diagnostics R&D, he developed recombinant proteins used in diagnostics tests, received three US patents, and published numerous papers and abstracts. Alan then transitioned to a quality assurance role wherein both the Abbott Diagnostics and Abbott Molecular divisions, he was responsible for quality assurance for new product development, on-market product support, and operations.Alan’s quality assurance experience extends from design control, change control, risk …
Upcoming Webinars
Navigating FDA Inspections: From SOP to 483
2-Hour Virtual Seminar on DeepSeek R1 for Business and Mark…
The Anti-Kickback Statute: Enforcement and Recent Updates
Risk Analysis in the Medical Device Design Process
2025 EEOC & Employers: Investigating Claims of Harassment …
How To Get Control of Your Day, Life & Career - Time Manage…
AI Across the Business: Practical Use Cases for Founders an…
Introduction to Microsoft Power BI Dashboards
Writing Effective 483 and Warning Letter Responses
6-Hour Virtual Seminar on Learning the Highlights of Excel …
FDA Recommendations for Artificial Intelligence/Machine Lea…
Female to Female Hostility @Workplace: All you Need to Know
Leadership: Strategic Planning and Decision Making
Writing Techniques for Auditors and Risk Management Profess…
Language is Code - Intro to AI - Generative AI - ChatGPT an…
Gossip-Free: Leadership Techniques to Quell Office Chatter
Do's and Don'ts of Giving Effective Feedback for Performanc…
4-Hour Virtual Seminar on Audit Proofing your Payroll Opera…
Retention Starts Here: Stop Losing Your Critical Talent and…
Do's and Don'ts of Documenting Employee Behaviour, Performa…
Practice Safe Stress ™: Preventing Burnout While Building R…
Impact Assessments For Supplier Change Notices
Cleanroom, Microbiology and Sterility Assurance Practices f…
Understanding EBITDA – Definition, Formula & Calculation
Thriving in a Hybrid Workplace: Keys to Leadership and Team…
2-Hour Virtual Seminar on DeepSeek vs ChatGPT AI for CPAs a…
Construction Lending And Real Credit Administration: Evalua…
How the OBBB Act will Impact Immigration Enforcement! Preve…
2-Hour Virtual Seminar on Outlook - Timesaving Tips and Tri…
Leadership Upskilling: Don’t Just Manage; Lead with Influen…
H-1B Visa Updates and Employer Strategies for 2026
Aligning Your HR Strategy with Your Business Strategy: A Ro…
HIPAA 2025 – Major Changes, Latest Rulings & Guidance
Excel Power Skills: Master Functions, Formulas, and Macros …